Ingenus Pharmaceuticals
Daniel Butterfield serves as the Associate Director of Quality Assurance at Avyxa Pharma, a startup focused on oncology drugs, since September 2023. With extensive experience in quality assurance management across various pharmaceutical companies, including Ingenus Pharmaceuticals and RiconPharma, Daniel has overseen site quality, managed teams, and ensured compliance with cGMP regulations. Previous roles include Senior Manager at Akorn, Inc., and R&D Chemist at Teva Pharmaceuticals. Daniel holds a Bachelor of Science degree in Biochemistry and Molecular Biology from Penn State University.
This person is not in any teams
This person is not in any offices
Ingenus Pharmaceuticals
1 followers
Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.